Author: Marketa Bielanova

High-quality evidence to guide treatment selection of chronic wound healing remains lacking. The conventional parallel-arm randomized controlled trial (RCT) model for wound healing studies has limitations. Complete wound closure as a primary endpoint necessitates trials with large sample sizes and prolonged follow-up to achieve adequate...

We are pleased to share that the geko device is now reimbursed in the UK, enabling clinicians to make a recommendation to the relevant approval committee within their local Integrated Care System (ICS) that the device should be considered for local formulary inclusion. In turn, reimbursement...